Aggressive restenosis after percutaneous intervention in two coronary loci in a patient with human immunodeficiency virus infection.

Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med (2003) 12.23

Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration. Lancet (2008) 8.73

Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. Lancet (2007) 6.77

Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. N Engl J Med (2006) 4.07

HIV and coronary heart disease: time for a better understanding. J Am Coll Cardiol (2013) 2.78

Protease inhibitors and cardiovascular outcomes in patients with HIV-1. Lancet (2002) 2.50

Long-Term Safety of Drug-Eluting and Bare-Metal Stents: Evidence From a Comprehensive Network Meta-Analysis. J Am Coll Cardiol (2015) 1.96

Cardiovascular disease in HIV infection. Am Heart J (2006) 1.78

A randomized comparison of sirolimus-eluting stent with balloon angioplasty in patients with in-stent restenosis: results of the Restenosis Intrastent: Balloon Angioplasty Versus Elective Sirolimus-Eluting Stenting (RIBS-II) trial. J Am Coll Cardiol (2006) 1.72

Clinical features of acute coronary syndromes in patients with human immunodeficiency virus infection. Circulation (2004) 1.68

Association of serum lipid levels with HIV serostatus, specific antiretroviral agents, and treatment regimens. J Acquir Immune Defic Syndr (2007) 1.66

Coronary in-stent restenosis: current status and future strategies. J Am Coll Cardiol (2002) 1.64

Restenosis: delineating the numerous causes of drug-eluting stent restenosis. Circ Cardiovasc Interv (2011) 1.32

Acute myocardial infarction in human immunodeficiency virus-infected patients. Arch Intern Med (2003) 1.08

Increased soluble markers of endothelial dysfunction in HIV-positive patients under highly active antiretroviral therapy. AIDS (2003) 1.04

Acute coronary syndrome in human immunodeficiency virus-infected patients: characteristics and 1 year prognosis. Eur Heart J (2010) 0.99

Outcome of percutaneous coronary intervention in HIV-infected patients. Catheter Cardiovasc Interv (2006) 0.92

Percutaneous coronary intervention in HIV infected patients: immediate results and long term prognosis. Heart (2006) 0.89

Comparison of outcomes using bare metal versus drug-eluting stents in coronary artery disease patients with and without human immunodeficiency virus infection. Am J Cardiol (2009) 0.85